All In MedTech

FDA Clearance Tracker

Clearance trends: Imaging AI & Software

How many devices FDA lets onto the market, in which specialties, and how long its reviews take. Counts are FDA decisions, not devices sold or used.

Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (newest decision)Source: openFDAMethods & limitations

Decisions per month: Imaging AI & Software

The last 36 months, by pathway. PMA counts are original approvals and panel-track supplements. The newest month is incomplete.

  • 510(k)
  • De Novo
  • PMA
View as table
Month510(k)De NovoPMA
Dec 231610
Jan 241310
Feb 24900
Mar 241300
Apr 241410
May 241600
Jun 241100
Jul 241600
Aug 241800
Sep 241300
Oct 242100
Nov 241800
Dec 241500
Jan 251400
Feb 251900
Mar 252000
Apr 251700
May 252010
Jun 251300
Jul 251800
Aug 251800
Sep 252200
Oct 251600
Nov 251000
Dec 251700
Jan 261300
Feb 261010
Mar 262200
Apr 262000
May 262100
Jun 262300
Jul 262400
Aug 261800
Sep 262300
Oct 261300
Nov 26600

See the Imaging AI & Software decisions

Decisions per year, by specialty

The 6 specialties with the most decisions since 2015. All specialties are in the table below. 2026 is a partial year.

  • Orthopedic Surgery
  • Radiology & Imaging
  • Cardiology
  • General & Plastic Surgery
  • Laboratory Medicine & Pathology
  • Hospital Medicine & Nursing
View as table
YearOrthopedic SurgeryRadiology & ImagingCardiologyGeneral & Plastic SurgeryLaboratory Medicine & PathologyHospital Medicine & Nursing
2015593348411290272182
2016477380392334265215
2017581396405323317237
2018523414397277296213
2019539354373273267199
2020546421370287196193
2021431409330517143368
2022429412354461198401
2023510455405396302271
2024453417361390263201
2025412483372386281194
2026 so far395416403327235131

Every specialty, year by year

510(k) clearances, De Novo grants, original PMA approvals and panel-track PMA supplements, grouped by FDA review panel.

Specialty201520162017201820192020202120222023202420252026*Total
Orthopedic Surgery5934775815235395464314295104534123955,889
Radiology & Imaging3483803964143544214094124554174834164,905
Cardiology4113924053973733703303544053613724034,573
General & Plastic Surgery2903343232772732875174613963903863274,261
Laboratory Medicine & Pathology2722653172962671961431983022632812353,035
Hospital Medicine & Nursing1822152372131991933684012712011941312,805
Dentistry & Oral Surgery2422322272102232592142502482612301952,791
GI, Urology & Nephrology1871792012352132091642042352232652192,534
Neurology & Neurosurgery1331452021741651611751762051992411892,165
Anesthesiology & Respiratory8395871007688706410297100831,045
Obstetrics & Gynecology9575899078797477768494951,006
Physical Medicine & Rehabilitation776958576459828181103113123967
Ophthalmology588073735455375651614340681
Otolaryngology (ENT)524235394331395253384550519

* 2026 is a partial year.

How long FDA takes to decide

Calendar days from the date FDA received the submission to the date it decided. This includes time the clock was stopped while FDA waited for the applicant, so it is longer than FDA's own review-day figures.

PathwayMedian daysMiddle halfBased on
510(k)13382 to 233The 1,000 most recent clearances, decided Jul 24, 2026 to Nov 8, 2026
De Novo326244 to 362The 150 most recent grants, decided 2023 to 2026
PMA (original)342226 to 529The 200 most recent approvals, decided 2020 to 2026

"Middle half" is the range from the 25th to the 75th percentile: half of the decisions in the sample took between those two numbers of days.

510(k) time to decision, by specialty

Median calendar days, from the same sample of recent 510(k) clearances. Specialties with fewer than 15 clearances in the sample are left out.

9 more in this ranking with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.